X

FDA Falls Behind on Sunscreen Approvals

By: Ashley Dao, PharmD Candidate c/o 2024 Melanoma is the fifth most common cause of cancer in the United States…

eMAR

Rho Chi Talks: The Path to Pharmaceutical Industry

Featuring: Fawad Piracha, PharmD, MBA, IgCP By: Holly Nguyen, PharmD Candidate ℅ 2024 Fawad Piracha is a ‘16 alumnus of…

eMAR

Zuranolone: An Oral Development in the Treatment of Postpartum Depression

By: Giavanna Carr, PharmD Candidate c/o 2025 Postpartum depression, also known as PPD, is classified as perinatal depression, which is…

eMAR

FDA Grants Approval for AREXVY, the First Respiratory Syncytial Virus (RSV) Vaccine

By: Urooj K. Malik, PharmD Candidate c/o 2024 On May 3, 2023, the United States (U.S.) Food and Drug Administration…

eMAR

6th Year Perspective: Conducting Research Projects and Attending Midyear

Featuring: Urooj K. Malik, PharmD Candidate c/o 2024 By: Isabelle Lim, PharmD Candidate c/o 2024 Urooj is a sixth-year pharmacy…

eMAR

Nationwide Albuterol Shortage: How Patients, Healthcare System, and Pharmaceutical Markets Have Been Affected

By: Celestine Van Sertima, PharmD Candidate c/o 2027 Addressing the Issue As the spring season leads the way to respiratory…

eMAR

The FDA’s Accelerated Approval of Lecanemab for Alzheimer’s Disease

By: Imaan Sekhery, PharmD Candidate c/o 2025 On January 6, 2023, the United States (U.S.) Food and Drug Administration (FDA)…

eMAR

The Use of Nitric Oxide Nasal Spray in Mild COVID-19 Infections

By: Isabelle Lim, PharmD Candidate c/o 2024 and Hadeel Aldasooky, PharmD Candidate c/o 2024 As the threat of coronavirus disease…

eMAR

Is Organic Food Really Worth It?

By: Sairah Sheikh, PharmD Candidate c/o 2024 In a world where people are becoming increasingly health-conscious, organic food is of…

eMAR

Rho Chi Talks: Transitioning to a PGY-2 Pediatric Pharmacy Residency

Featuring: Nicole Cernaro, PharmD, PGY-2 Pediatric Pharmacy Resident By: Urooj K. Malik, PharmD Candidate c/o 2024 Nicole Cernaro is a…

eMAR